Frank D. Lee
Net Worth
Last updated:
What is Frank D. Lee net worth?
The estimated net worth of Mr. Frank D. Lee is at least $9,031,996 as of 23 Feb 2022. He owns shares worth $1,596,178 as insider, has earned $175,818 from insider trading and has received compensation worth at least $7,260,000 in Forma Therapeutics Holdings, Inc..
What is the salary of Frank D. Lee?
Mr. Frank D. Lee salary is $2,420,000 per year as Pres, Chief Executive Officer & Director in Forma Therapeutics Holdings, Inc..
How old is Frank D. Lee?
Mr. Frank D. Lee is 57 years old, born in 1968.
What stocks does Frank D. Lee currently own?
As insider, Mr. Frank D. Lee owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. (FMTX) | Pres, Chief Executive Officer & Director | 79,769 | $20.01 | $1,596,178 |
What does Forma Therapeutics Holdings, Inc. do?
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc. operates as a subsidiary of Novo Nordisk A/S.
Frank D. Lee insider trading
Forma Therapeutics Holdings, Inc.
Mr. Frank D. Lee has made only one insider trade in 2022, according to the Form 4 filled with the SEC. He sold 17,981 units of FMTX stock worth $175,818 on 23 Feb 2022.
As of 23 Feb 2022 he still owns at least 79,769 units of FMTX stock.
Forma Therapeutics Holdings key executives
Forma Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC:
- Dr. Patrick F. Kelly M.D. (61) Senior Vice President & Chief Medical Officer
- Mr. Frank D. Lee (57) Pres, Chief Executive Officer & Director
- Mr. Todd E. Shegog (60) Senior Vice President & Chief Financial Officer